This blend is studied in receptor models involving GHRH and growth-hormone secretagogue signaling, ligand interaction, and pathway crosstalk.
- GHRH receptor signaling
- GHSR receptor signaling
- Receptor-pathway crosstalk
The blend report lists two masses, not one purity
7.27 mg for CJC-1295 (mod GRF 1-29) and 5.97 mg for Ipamorelin, task 121834.
This page will not tell you how to combine them. They are already one catalog listing.
Price versus the single
The blend is $49.99. Ipamorelin 10 mg alone is $39.99. You are not buying the same vial.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg research questions
Is there a purity percent?
Not on task 121834.
What is the labeled amount?
5 mg CJC-1295 (No DAC) and 5 mg Ipamorelin.
References and further reading
- PubMed literature index — CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.